The medial temporal lobe in schizophrenia

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 9, Issue 3, 1997, Pages 460-470

  Arnold, Steven E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSKELETON PROTEIN;

AUTOPSY; BRAIN BLOOD FLOW; ENTORHINAL CORTEX; HIPPOCAMPUS; HUMAN; INNERVATION; LEARNING; MEMORY; MONOAMINERGIC SYSTEM; NEUROANATOMY; NEUROBIOLOGY; NEUROPSYCHIATRY; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYNAPSE; TEMPORAL LOBE;

EID: 0030742133     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.9.3.460     Document Type: Review

References (137)

1. Kraepelin E: Dementia Praecox and Paraphrenia. Edinburgh, Livingstone, 1919
2. Kleist K: Schizophrenic symptoms and cerebral pathology. J Ment Sci 1960; 106:246-255
3. Da vison K, Bagley CR: Schizophrenia-like psychoses associated with organic disorders of the CNS: a review of the literature, in Current Problems in Neuropsychiatry, part II, edited by Herrington P. Br J Psychiatry Special Publication No 4. Ashford, UK, Headley Bros, 1969, pp 113-184
4. Davison K: Schizophrenia-like psychoses associated with organic cerebral disorders: a review. Psychiatric Development 1983; 1:1-34
5. Cummings JL: Organic psychosis. Psychosomatics 1988; 29:16-26
6. Fricchione GL, Carbone L, Bennet WI: Psychotic disorder caused by a general medical condition, with delusions. Psychiatr Clin North Am 1995; 18:363-378
7. Jacobi W, Winkler H: Untersuchungen des Liquor cerebrospinalis mit dem zeisschen Spektographan für Chemiker. Deutch Ztschr f Nervenh 1929; 111:5-18
8. Ellingson RJ : The incidence of EEG abnormality among patients with mental disorders of apparently nonorganic origin: a critical review. Am J Psychiatry 1954; 111:263-285
9. Shapiro RM: Regional neuropathology in schizophrenia: Where are we? Where are we going? Schizophr Res 1993; 10:187-239
10. Arnold SE, Trojanowski JQ: Recent advances in defining the neuropathology of schizophrenia. Acta Neuropathol 1996; 42:217-231
11. Goldman-Rakic PS: Working memory dysfunction in schizophrenia. J Neuropsychiatry Clin Neurosci 1994; 6:348-357
12. Sedvall G, Farde L: Chemical brain anatomy in schizophrenia. Lancet 1995; 346:743-749
13. Damasio H, Damasio AR: Lesion Analysis in Neuropsychology. New York, Oxford University Press, 1989
14. Saykin AJ, Gur RC, Gur RE, et al: Neuropsychological function in schizophrenia: selective impairment in memory and learning. Arch Gen Psychiatry 1991; 48:618-624
15. Saykin AJ, Shtasel DL, Gur RE, et al: Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Arch Gen Psychiatry 1994; 51:124-131
16. Gur RE, Cowell P, Turetsky BI, et al: A follow-up study of neuroanatomical, clinical, and neurobehavioral measures in schizophrenia. Arch Gen Psychiatry (in press)
17. Gruzelier J, Seymour K, Wilson J: Impairments on neuropsychological tests of temporohippocampal and frontohippocampal functions and word fluency in remitting schizophrenic and affective disorders. Arch Gen Psychiatry 1988; 45:623-629
18. McKenna P, Tamlyn D, Lund C, et al: Amnesic syndrome in schizophrenia. Psychol Med 1990; 20:967-972
19. Gold JM, Randolph C, Carpenter CJ, et al: Forms of memory failure in schizophrenia. J Abnorm Psychol 1992; 101:487-494
20. Tamlyn D, McKenna PJ, Mortimer AM, et al: Memory impairment in schizophrenia: its extent, affiliations and neuropsychological character. Psychol Med 1992; 22:101-115
21. Gold JM, Weinberger DR: Cognitive deficits and the neurobiology of schizophrenia. Curr Opin Neurobiol 1995; 5:225-230
22. Kelsoe JR, Cadet JL, Pickar D, et al: Quantitative neuroanatomy in schizophrenia: a controlled magnetic resonance imaging study. Arch Gen Psychiatry 1988; 45:533-541
23. Pearlson GD, Kim WS, Kubos KL, et al: Ventricle-brain ratio, computed tomographic density, and brain area in 50 schizophrenics. Arch Gen Psychiatry 1989; 46:690-697
24. Gur RE, Mozley PD, Resnick SM, et al: Magnetic resonance imaging in schizophrenia, I: volumetric analysis of brain and cerebrospinal fluid. Arch Gen Psychiatry 1991; 48:407-412
25. Suddath RL, Casanova MF, Goldberg TE, et al: Temporal lobe pathology in schizophrenia: a quantitative magnetic resonance imaging study. Am J Psychiatry 1989; 146:464-472
26. Suddath RL, Christison GW, Torrey EF, et al: Cerebral anatomic abnormalities in monozygotic twins discordant for schizophrenia. N Engl J Med 1990; 322:789-794
27. Bogerts B, Ashtari M, Degreef G, et al: Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Res Neuroimaging 1990; 35:1-13
28. Breier A, Buchanan RW, Elkashef A, et al: Brain morphology and schizophrenia: a magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. Arch Gen Psychiatry 1992; 49:921-926
29. Shenton ME, Kikinis R, Jolesz FA: Abnormalities of the left temporal lobe and thought disorder in schizophrenia: a quantitative magnetic resonance imaging study. N Engl J Med 1992; 327:604-612
30. Zipursky RB, Lim KO, Sullivan EV, et al: Widespread cerebral gray matter volume deficits in schizophrenia. Arch Gen Psychiatry 1992; 49:195-205
31. Zipursky RB, Marsh L, Lim KO: Volumetric MRI assessment of temporal lobe structures in schizophrenia. Biol Psychiatry 1994; 35:501-516
32. Goldberg TE, Torrey EF, Berman KF, et al: Relations between neuropsychological performance and brain morphological and physiological measures in monozygotic twins discordant for schizophrenia. Psychiatry Res 1994; 55:51-61
33. Nestor PG, Shenton ME, McCarley RW, et al: Neuropsychological correlates of MRI temporal lobe abnormalities in schizophrenia. Am J Psychiatry 1993; 150:1849-1855
34. Bogerts B, Lieberman JA, Ashtari M, et al: Hippocampus-amygdala volumes and psychopathology in chronic schizophrenia. Biol Psychiatry 1993; 33:236-246
35. Turetsky B, Cowell PE, Gur RC, et al: Frontal and temporal brain volumes in schizophrenia. Arch Gen Psychiatry 1995; 52:1061-1070
36. Bilder RM, Bogerts B, Ashtari M, et al: Anterior hippocampal volume reductions predict frontal lobe dysfunction in first episode schizophrenia. Schizophr Res 1995; 17:47-58
37. Arnold SE, Hyman BT, Hoesen GWV, et al: Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch Gen Psychiatry 1991; 48:625-632
38. Weinberger DR: From neuropathology to neurodevelopment. Lancet 1995; 346:552-557
39. Lipska BK, Jaskiw GE, Weinberger DR: Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology 1993; 9:67-75
40. Tamminga CA, Thaker GK, Buchanan R, et al: Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch Gen Psychiatry 1992; 49:522-530
41. Friston KJ, Liddle PF, Frith CD, et al: The left medial temporal region and schizophrenia: a PET study. Brain 1992; 115:367-382
42. Schroeder J, Buchsbaum MS, Siegel BV, et al: Structural and functional correlates of subsyndromes in chronic schizophrenia. Psychopathology 1995; 28:38-45
43. Silbersweig DA, Stern E, Frith C, et al: A functional neuroanatomy of hallucinations in schizophrenia. Nature 1995; 378:176-179
44. Weinberger DR, Berman KF, Zee RF: Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia, I: regional cerebral blood flow evidence. Arch Gen Psychiatry 1986; 43:11-19
45. Berman KF, Torrey EF, Daniel DG, et al: Regional cerebral blood flow in monozygotic twins discordant and concordant tor schizophrenia. Arch Gen Psychiatry 1992; 49:927-934
46. Weinberger DR, Berman KF, Suddath R, et al: Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins. Am J Psychiatry 1992; 149:890-897
47. Humberstone MR, Sawle GV: Functional magnetic resonance imaging in clinical neurology. Eur Neurol 1996; 26:117-124
48. Saykin AJ, Riordan HJ, Weaver JB, et al: Memory activation in schizophrenia: preliminary observations using functional magnetic resonance imaging (FMRI) (abstract). Schizophr Res 1995; 15:97
49. Nasrallah HA, Skinner TE, Schmalbrock P, et al: Proton magnetic resonance spectroscopy (1H MRS) of the hippocampal formation in schizophrenia: a pilot study. Br J Psychiatry 1994; 165:481-485
50. Fukuzako H, Takeuchi K, Hokazono Y, et al: Proton magnetic-resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: a preliminary report. Psychiatry Res 1995; 61:193-200
51. Maier M, Ron MA, Barker GJ, et al: Proton magnetic spectroscopy: an in vivo method of estimating hippocampal neuronal depletion in schizophrenia. Psychol Med 1995; 25:1201-1209
52. Renshaw PF, Yurgelun-Todd DA, Tohen M, et al: Temporal-lobe proton magnetic-resonance spectroscopy of patients with first episode psychosis. Am J Psychiatry 1995; 153:444-446
53. Abrams R, Taylor MA: Differential EEG patterns in affective disorder and schizophrenia. Arch Gen Psychiatry 1979; 36:1355-1361
54. Heath RG: Correlation of electrical recordings from cortical and subcortical regions of the brain with abnormal behavior in human subjects. Confin Neurol 1958; 18:305-315
55. Sem-Jacobsen CW, Petersen MC, Lazarte J, et al: Intracerebral electrographic recordings from psychotic patients during hallucinations and agitation. Am J Psychiatry 1955; 112:278-288
56. Baribeau-Braun J, Picton TW, Gosselin J-Y: Schizophrenia: a neurophysiological evaluation of abnormal information processing. Science 1983; 219:874-876
57. Pritchard WS: Cognitive event-related potential correlates of schizophrenia. Psychol Bull 1986; 100:43-66
58. Duncan CC, Perlstein WM, Morihisa JM: The P300 metric in schizophrenia: effects of probability and modality, in Current Trends in Event Related Potential Research (EEG Supplement 40), edited by Johnson JR, Rohrbaugh JW, Parasurman R. Amsterdam, Elsevier Science, 1987, pp 670-674
59. Egan MF, Duncan CC, Suddath RL, et al: Event-related potential abnormalities correlate with structural brain alterations and clinical features in patients with chronic schizophrenia. Schizophr Res 1994; 11:259-271
60. Proceedings of the First International Congress of Neuropathology, vol 1. Turin, Italy, Rosenberg and Sellier, 1952
61. Bruton CJ, Crow TJ, Frith CD, et al: Schizophrenia and the brain: a prospective clinico-neuropathological study. Psychol Med 1990; 20:285-304
62. Stevens JR: Neuropathology of schizophrenia. Arch Gen Psychiatry 1982; 39:1131-1139
63. Arnold SE, Gur RE, Shapiro RM, et al: Prospective clinicopathological studies of schizophrenia: accrual and assessment. Am J Psychiatry 1995; 152:731-737
64. Golier JA, Davidson M, Haroutunian V, et al: Neuropathological study of 101 elderly schizophrenics: preliminary findings. Schizophr Res 1995; 15:120
65. Bogerts B, Meertz E, Schonfeldt-Bausch R: Basal ganglia and limbic system pathology in schizophrenia. Arch Gen Psychiatry 1985; 42:784-791
66. Brown R, Colter N, Corsellis JAN, et al: Postmortem evidence of structural brain changes in schizophrenia. Arch Gen Psychiatry 1986; 43:36-42
67. Colter N, Battal S, Crow TJ, et al: White matter reduction in the parahippocampal gyrus of patients with schizophrenia. Arch Gen Psychiatry 1987; 44:1023-1029
68. Falkai P, Bogerts B, Rozumek M: Limbic pathology in schizophrenia: the entorhinal region: a morphometric study. Biol Psychiatry 1988; 24:515-521
69. Jeste DV, Lohr JB: Hippocampal pathologic findings in schizophrenia: a morphometric study. Arch Gen Psychiatry 1989; 46:1019-1024
70. Altshuler LL, Casanova MF, Goldberg TE, et al: The hippocampus and parahippocampus in schizophrenic, suicide, and control brains. Arch Gen Psychiatry 1990; 47:1029-1034
71. Bogerts B, Falkai P, Haupts M, et al: Post-mortem volume measuremerits of limbic system and basal ganglia structures in chronic schizophrenics: initial results from a new brain collection. Schizophr Res 1990; 3:295-301
72. Heckers S, Heinsen H, Heinsen YC, et al: Limbic structures and lateral ventricle in schizophrenia: a quantitative postmortem study. Arch Gen Psychiatry 1990; 47:1016-1022
73. Heckers S, Heinsen H, Geiger B, et al: Hippocampal neuron number in schizophrenia: a stereological study. Arch Gen Psychiatry 1991; 48:1002-1008
74. Pakkenberg B: Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenia. Arch Gen Psychiatry 1990; 47:1023-1028
75. Falkai P, Bogerts B: Cell loss in the hippocampus of schizophrenics. Eur Arch Psychiatry Neurol Sci 1986; 236:154-161
76. Krimer LS, Herman MM, Saunders RC, et al: Qualitative and quantitative analysis of the entorhinal cortex cytoarchitectural organization in schizophrenia (abstract). Society for Neuroscience Abstracts 1995; 21:239
77. Kovelman JA, Scheibel AB: A neurohistological correlate of schizophrenia. Biol Psychiatry 1984; 19:1601-1621
78. Benes FM, Sorensen I, Bird ED: Reduced neuronal size in posterior hippocampus of schizophrenic patients. Schizophr Bull 1991; 17:597-608
79. Arnold SE, Franz BR, Gur RC, et al: Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. Am J Psychiatry 1995; 152:738-748
80. Rajkowska G, Selemon LD, Goldman-Rakic PS: Reduction in neuronal sizes in prefrontal cortex of schizophrenics and Huntington patients (abstract). Society for Neuroscience Abstracts 1994; 20:620
81. Scheibel AB, Kovelman JB: Disorientation of the hippocampal pyramidal cell and its processes in the schizophrenic patient. Biol Psychiatry 1981; 16:101-102
82. Conrad AJ, Abebe T, Austin R, et al: Hippocampal pyramidal cell disarray in schizophrenia as a bilateral phenomenon. Arch Gen Psychiatry 1991; 48:413-417
83. Altshuler LL, Conrad A, Kovelman JA, et al: Hippocampal pyramidal cell orientation in schizophrenia. Arch Gen Psychiatry 1987; 44:1094-1098
84. Christison GW, Casanova MF, Weinberger DR, et al: A quantitative investigation of hippocampal pyramidal cell size, shape, and variability of orientation in schizophrenia. Arch Gen Psychiatry 1989; 46:1027-1032
85. Jakob H, Beckmann H: Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm 1986; 65:303-326
86. Jakob H, Beckmann H: Gross and histological criteria for developmental disorders in brains of schizophrenics. J R Soc Med 1989; 82:466-469
87. Jakob H, Beckmann H: Circumscribed malformation and nerve cell alterations in the entorhinal cortex of schizophrenics: pathogenetic and clinical aspects. J Neural Transm 1994; 98:83-106
88. Van Hoesen GW: The parahippocampal gyrus: new observations regarding its cortical connections in the monkey. Trends Neurosci 1982; 5:345-350
89. Arnold SE, Ruscheinsky DR, Han L-Y: Further evidence of abnormal cytoarchitecture of the entorhinal cortex in schizophrenia using spatial point pattern analyses. Biol Psychiatry 1997 (in press)
90. Nowakowski RS, Rakic P: The site of origin and route and rate of migration of neurons to the hippocampal region in the rhesus monkey. J Comp Neurol 1981; 196:129-154
91. Arnold SE, Trojanowski JQ: Human fetal hippocampal development, I: cytoarchitecture, myeloarchitecture and neuronal morphology. J Comp Neurol 1996; 367:274-292
92. Arnold SE, Trojanowski JQ: Human fetal hippocampal development, II: the neuronal cytoskeleton. J Comp Neurol 1996; 367:293-307
93. Frith CD, Done DJ: Towards a neuropsychology of schizophrenia. Br J Psychiatry 1988; 1988:437-443
94. Gray JA, Feldern J, Rawlins JNP, et al: The neuropsychology of schizophrenia. Behav Brain Sci 1991; 14:1-84
95. Benes FM: Neurobiological investigations in cingulate cortex of schizophrenic brain. Schizophr Bull 1993; 19:537-549
96. Stevens JR: Abnormal synaptic reinnervation as the basis of schizophrenia: a hypothesis. Arch Gen Psychiatry 1992; 49:238-243
97. Eastwood SL, McDonald B, Burnet PW, et al: Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia. Brain Res Molec Brain Res 1995; 29:211-223
98. Eastwood SL, Burnet PWJ, Harrison PJ: Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neurosci 1995; 66:309-319
99. Browning MD, Dudek EM, Rapier JL, et al: Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics. Biol Psychiatry 1993; 34:529-535
100. Glantz LA, Lewis DA: Assessment of spine density on layer III pyramidal cells in the prefrontal cortex of schizophrenic subjects (abstract). Society for Neuroscience Abstracts 1995; 21:239
101. Glantz LA, Lewis DA: Specificity of decreased spine density on layer III pyramidal cells in schizophrenia (abstract). Society for Neuroscience Abstracts 1996; 22:1679
102. Ong WY, Garey LJ: Ultrastructural features of biopsied temporopolar cortex (area 38) in a case of schizophrenia. Schizophr Res 1993; 10:15-27
103. Longson D, Deakin JFW, Benes FM: Increased density of entorhinal glutamate-immunoreactive vertical fibers in schizophrenia. J Neural Transm 1996; 103:503-507
104. Kleinman JE, Casanova MF, Jaskiw GE: The neuropathology of schizophrenia. Schizophr Bull 1988; 14:209-216
105. Seeman P, Niznik HB: Dopamine receptors and transporters in Parkinson's disease and schizophrenia. FASEB 1990; 4:2737-2744
106. Reynolds GP: Beyond the dopamine hypothesis: the neurochemical pathology of schizophrenia. Br J Psychiatry 1989; 155:305-316
107. Joyce JN: The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine. Psychopharmacol (Berl) 1993; 112:S16-534
108. Reynolds GP: Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia. Nature 1983; 305:527-529
109. Winblad B, Blucht G, Gotfries CG, et al: Monoamines and monoamine metabolites in brains from demented schizophrenics. Acta Psychiatr Scand 1979; 60:17-28
110. Akil M, Lewis DA: The catecholaminergic innervation of the human entorhinal cortex: alterations in schizophrenia (abstract). Society for Neuroscience Abstracts 1995; 21:238
111. Joyce JN, Shane A, Lexow N, et al: Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacology 1993; 8:315-336
112. Joyce JN, Lexow N, Kim SJ, et al: Distribution of beta-adrenergic receptor subtypes in human post-mortem brains: alterations in limbic regions of schizophrenics. Synapse 1992; 10:228-246
113. Kim JS, Kornhuber HH, Schmid-Burgk W, et al: Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett 1980; 30:379-382
114. Olney JW, Farber NB: Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 1995; 52:998-1007
115. Javitt DC, Zukin SR: Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 1991; 148:1301-1308
116. Mattson MP: Cellular signaling mechanisms common to the development and degeneration of neuroarchitecture: a review. Mech Ageing Dev 1989; 50:103-157
117. Kerwin RW, Beats BC: Increased forskolin binding in the left parahippocampal gyrus and CA 1 region in post mortem schizophrenic brain determined by quantitative autoradiography. Neurosci Lett 1990; 118:164-168
118. Simpson MDC, Royston MC, Slater P, et al: Phencyclidine and sigma receptor abnormalities in schizophrenic post-mortem brain (abstract). Schizophr Res 1990; 3:32
119. Deakin JFW, Slater P, Simpson MDC, et al: Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. J Neurochem 1989; 52:1781-1786
120. Tsai G, Passani LA, Slusher BS, et al: Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry 1995; 52:829-836
121. Norton WT, Aquino DA, Hozumi I, et al: Quantitative aspects of reactive gliosis: a review. Neurochem Res 1992; 17:877-885
122. Stevens CD, Altshuler LL, Bogerts B, et al: Quantitative study of gliosis in schizophrenia and Huntington's chorea. Biol Psychiatry 1988; 24:697-700
123. Crow TJ, Ball J, Bloom SR, et al: Schizophrenia as an anomaly of development of cerebral asymmetry: a postmortem study and a proposal concerning the genetic basis of the disease. Arch Gen Psychiatry 1989; 46:1145-1150
124. Arnold SE, Trojanowski JQ, Gur RE, et al: Investigations of neurodegeneration and neural injury in the brains of elderly patients with schizophrenia. Society for Neuroscience Abstracts 1995
125. Benes FM, Davidson J, Bird ED: Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Arch Gen Psychiatry 1986; 43:31-35
126. Selemon LD, Rajkowska G, Goldman-Rakic PS: Abnormally high neuronal density in the schizophrenic cortex: a morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry 1995; 52:805-818
127. Purohit DP, Davidson M, Perl DP, et al: Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological study. Biol Psychiatry 1993; 33:255-260
128. Powchik P, Davidson M, Nemeroff CB, et al: Alzheimer's-disease-related protein in geriatric schizophrenic patients with cognitive impairment. Am J Psychiatry 1993; 150:1726-1727
129. Arnold SE, Franz BR, Trojanowski JQ: Elderly patients with schizophrenia exhibit infrequent neurodegenerative lesions. Neurobiol Aging 1994; 15:299-303
130. Barbeau D, Liang JJ, Robitaille Y, et al: Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains. Proc Natl Acad Sci USA 1995; 92:2785-2789
131. Mednick SA, Machon RA, Huttunen MO, et al: Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry 1988; 45:189-192
132. Wright P, Takei N, Rifkin L, et al: Maternal influenza, obstetric complications, and schizophrenia. Am J Psychiatry 1995; 152:1714-1720
133. Arnold SE, Lee VMY, Gur RE, et al: Abnormal expression of two microtubule-associated proteins (MAP2 and MAPS) in specific subfields of the hippocampal formation in schizophrenia. Proc Natl Acad Sci USA 1991; 88:10850-10854
134. Rosoklija G, Kaufman MA, Liu D, et al: Subicular MAP-2 immunore-activity in schizophrenia (abstract). Society for Neuroscience Abstracts 1995; 21:2126
135. Lipska BK, Weinberger DR: Behavioral effects of subchronic treatment with haloperidol or clozapine in rats with neonatal excitotoxic hippocampal damage. Neuropsychopharmacology 1994; 10:199-205
136. Lipska BK, Swerdlow NR, Geyer MA, et al: Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacol 1995; 122:35-43
137. Bardgett ME, Jackson JL, Taylor GT, et al: Kainic acid decreases hippocampal neuron number and increases dopamine receptor binding in the nucleus accumbens: an animal model of schizophrenia. Behav Brain Res 1995; 70:153-164